Top Tweets for #EurJCancer

over 5 years ago

Terminology to describe what extent of resection has been achieved after surgery for diffuse glioma is inconsistent - read here our thoughts in #EurJCancer on how to standardize nomenclature. Proud on this international team effort! And it’s open access: https://t.co/xn9b78xMaA

Sebastian F. Winter, MD PhD @SebastianWinter

almost 6 years ago

Latest publication out in #EurJCancer: We illustrate a rare but fatal case of #fludarabine-associated #neurotoxicity in the setting of adoptive #immunotherapy & discuss diagnostic differentiation from common #CART-cell therapy related neurologic complications like #ICANS.

SebastianWinter's tweet photo. Latest publication out in #EurJCancer:

We illustrate a rare but fatal case of #fludarabine-associated #neurotoxicity in the setting of adoptive #immunotherapy & discuss diagnostic differentiation from common #CART-cell therapy related neurologic complications like #ICANS. https://t.co/p6YFq0I8Uk

Carlos Alvarez @duemed

over 7 years ago

Grouping of drugs by immune-modulating pathway. From "The evolving landscape of ‘next-generation’ immune checkpoint inhibitors" #EurJCancer #EuropeanInstituteOfCancer Very interesting review. https://t.co/UNXmQLLEPS

duemed's tweet photo. Grouping of drugs by immune-modulating pathway.
From "The evolving landscape of ‘next-generation’ immune checkpoint inhibitors" #EurJCancer #EuropeanInstituteOfCancer Very interesting review. https://t.co/UNXmQLLEPS https://t.co/fT20EviD3l

Gabriela Guillén @Guillen_CirPed

over 7 years ago

Los nuevos fármacos antitumorales aprobados por la FDA tardan más de 6 años en llegar a los pacientes pediátricos, según un estudio publicado en el #EurJCancer. Es imprescindible acelerar este proceso #cáncerpediátrico #medicinapersonalizada 👇🏻https://t.co/YWqOUYjAeq

Top Tweets for #EurJCancer

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users